Table 3.
Comparison of mortality rate between the higher and lower group divided by median values of lymphocyte count in HBV-related ACLF patients.
| Mortality (n, %) | Lower group | Higher group | P-value |
|---|---|---|---|
| CD3+ T cells (cells/μl) | 15 (42.9) | 6 (17.1) | 0.019 |
| CD4+ T cells (cells/μl) | 14 (40.0) | 7 (20.0) | 0.068 |
| CD8+ T cells (cells/μl) | 15 (42.9) | 6 (17.1) | 0.019 |
| CD19+ B cells (cells/μl) | 13 (37.1) | 8 (22.9) | 0.192 |
| CD56+CD16+ NK cells (cells/μl) | 12 (34.3) | 9 (25.7) | 0.434 |